Plus Therapeutics Inc is a biotechnology company focused on developing innovative therapies for cancer treatment
The company utilizes a proprietary nanoscale particle technology aimed at delivering targeted, localized therapies to improve patient outcomes while minimizing systemic side effects. Their pipeline includes treatments designed to address various types of cancer, with a particular emphasis on rare and hard-to-treat indications. Through its research and development efforts, Plus Therapeutics is committed to advancing the science of cancer care and providing new options for patients facing challenging diagnoses.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
HOUSTON, TX / ACCESS Newswire / March 11, 2025 / On March 4th, Plus Therapeutics, Inc. (Nasdaq:PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announced the pricing of a private placement with gross proceeds to the Company expected to be approximately $15.0 million.
Stay updated with the latest market activity on Friday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
